Ritalin³ Research Fraud

The use of the drug Ritalinƒ, commonly given to hyperactive children, is again under scrutiny. Dr. Stephen Breuning, the psychologist who first researched the medication, pleaded guilty in U.S. federal court (9/89) to falsifying his findings.

A National Institute of Mental Health (NIMH) investigation showed that Breuning, who was responsible for one-third of the literature on drug therapy for hyperactive children during his research years, "knowingly, willfully and repeatedly engaged in misleading and deceptive practices in reporting results of research," (Ginsburg, S. Baltimore [UPI], November 11, 1989). Accordingly, the research was never done as described in the grant application to the NIMH, and the results Breuning claimed were never attained. It was the first federal conviction of a researcher for falsifying results.

Breuning was sentenced to 60 days in prison, ordered to pay $11,352 in restitution to the University of Pittsburgh (where Breuning worked), and was placed on five years probation by U.S. District Judge Frank Kaufman, who said the former researcher "will pay dearly for the rest of his life."

The use of Ritalinƒ is still controversial and has resulted in numerous court battles between schools and parents. Some doctors say the benefits — increased attention span and performance—outweigh the side affects which may include twitching, depression, violence and sometimes suicidal tendencies.

Other doctors feel that most hyperactive children can be treated using more conservative measures. While many of those using A.K have experienced excellent results with these children, further studies are needed to provide a better understanding of this complex problem.

Return to Personal index